JP2024507929A5 - - Google Patents

Info

Publication number
JP2024507929A5
JP2024507929A5 JP2023551669A JP2023551669A JP2024507929A5 JP 2024507929 A5 JP2024507929 A5 JP 2024507929A5 JP 2023551669 A JP2023551669 A JP 2023551669A JP 2023551669 A JP2023551669 A JP 2023551669A JP 2024507929 A5 JP2024507929 A5 JP 2024507929A5
Authority
JP
Japan
Prior art keywords
polynucleotide sequence
amino acid
seq
acid sequence
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023551669A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507929A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/070690 external-priority patent/WO2022183167A1/en
Publication of JP2024507929A publication Critical patent/JP2024507929A/ja
Publication of JP2024507929A5 publication Critical patent/JP2024507929A5/ja
Pending legal-status Critical Current

Links

JP2023551669A 2021-02-25 2022-02-17 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法 Pending JP2024507929A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202163153862P 2021-02-25 2021-02-25
US63/153,862 2021-02-25
US202163159434P 2021-03-10 2021-03-10
US63/159,434 2021-03-10
US202163260409P 2021-08-19 2021-08-19
US63/260,409 2021-08-19
US202163260855P 2021-09-02 2021-09-02
US63/260,855 2021-09-02
US202263267421P 2022-02-01 2022-02-01
US63/267,421 2022-02-01
PCT/US2022/070690 WO2022183167A1 (en) 2021-02-25 2022-02-17 Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024507929A JP2024507929A (ja) 2024-02-21
JP2024507929A5 true JP2024507929A5 (cg-RX-API-DMAC10.html) 2025-02-25

Family

ID=80628943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023551669A Pending JP2024507929A (ja) 2021-02-25 2022-02-17 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法

Country Status (8)

Country Link
US (1) US20240175047A1 (cg-RX-API-DMAC10.html)
EP (1) EP4298121A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024507929A (cg-RX-API-DMAC10.html)
KR (1) KR20230150336A (cg-RX-API-DMAC10.html)
AU (1) AU2022227085A1 (cg-RX-API-DMAC10.html)
CA (1) CA3209732A1 (cg-RX-API-DMAC10.html)
IL (1) IL305393A (cg-RX-API-DMAC10.html)
WO (1) WO2022183167A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230159614A1 (en) * 2020-02-26 2023-05-25 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Hla class ii-restricted t cell receptors against ras with g12v mutation
WO2023150562A1 (en) * 2022-02-01 2023-08-10 Alaunos Therapeutics, Inc. Methods for activation and expansion of t cells
WO2023183344A1 (en) 2022-03-21 2023-09-28 Alaunos Therapeutics, Inc. Methods for identifying neoantigen-reactive t cell receptors
JP2025530339A (ja) * 2022-09-13 2025-09-11 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 変異型rasを標的化するためのt細胞受容体及びその組成物
WO2024163371A1 (en) * 2023-01-30 2024-08-08 Fred Hutchinson Cancer Center Binding proteins specific for mutant p53 and uses thereof
WO2024197072A2 (en) 2023-03-21 2024-09-26 Alaunos Therapeutics, Inc. Identification of neoantigen-reactive t cell receptors
AU2024241888A1 (en) * 2023-03-27 2025-10-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors targeting y220c or r175h mutation in p53
CN117143823B (zh) * 2023-09-11 2024-07-16 皖南医学院第一附属医院(皖南医学院弋矶山医院) 一种基于tcr单链可变区的靶向ras(g12v)的嵌合抗原受体记忆nk细胞的研制及其应用
WO2025056681A1 (en) * 2023-09-15 2025-03-20 Medigene Immunotherapies Gmbh T-CELL RECEPTOR AGAINST mKRAS7-16 G12V AND G12C
WO2025096983A1 (en) * 2023-11-02 2025-05-08 Board Of Regents, The University Of Texas System Peptides and engineered t cell receptors targeting tpx2 antigen and methods of use

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996018105A1 (en) 1994-12-06 1996-06-13 The President And Fellows Of Harvard College Single chain t-cell receptor
DK0973928T3 (da) 1997-03-11 2010-08-09 Univ Minnesota DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
GB9809658D0 (en) 1998-05-06 1998-07-01 Celltech Therapeutics Ltd Biological products
IL127142A0 (en) 1998-11-19 1999-09-22 Yeda Res & Dev Immune cells having predefined biological specificity
JP2002541845A (ja) 1999-04-16 2002-12-10 セルテック セラピューティックス リミテッド 合成膜貫通成分
PT1421115E (pt) 2001-08-31 2005-07-29 Avidex Ltd Receptor de celulas t soluvel
US20040014194A1 (en) 2002-03-27 2004-01-22 Schering Corporation Beta-secretase crystals and methods for preparing and using the same
WO2003089618A2 (en) 2002-04-22 2003-10-30 Regents Of The University Of Minnesota Transposon system and methods of use
AU2003271904B2 (en) 2002-10-09 2009-03-05 Adaptimmune Limited Single chain recombinant T cell receptors
EP1791865B1 (en) 2004-06-29 2010-07-28 Immunocore Ltd. Cells expressing a modified t cell receptor
GB0712670D0 (en) 2007-06-29 2007-08-08 King S College London Isolated peptides and uses thereof
US9228180B2 (en) 2007-07-04 2016-01-05 Max-Delbruck-Centrum Fur Molekulare Medizin Polypeptide variants of sleeping beauty transposase
WO2011044186A1 (en) 2009-10-06 2011-04-14 The Board Of Trustees Of The University Of Illinois Human single-chain t cell receptors
CA3285826A1 (en) 2012-02-22 2026-03-02 The Trustees Of The University Of Pennsylvania Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer
PT2692865E (pt) 2012-07-30 2015-02-06 Nbe Therapeutics Llc Identificação mediada por transposição de proteínas funcionais ou de ligação específicas
SG10201913978RA (en) 2014-11-26 2020-03-30 The United States Of America As Represented By The Secretary Anti-mutated kras t cell receptors
JP6775515B2 (ja) 2015-03-11 2020-10-28 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム トランスポザーゼポリペプチド及びその使用
SG10201913868XA (en) 2015-09-15 2020-03-30 The United States Of America As Represented By The Secretary T cell receptors recognizing hla-cw8 restricted mutated kras
SG11201900654QA (en) 2016-08-02 2019-02-27 Us Health Anti-kras-g12d t cell receptors
WO2018209115A1 (en) 2017-05-10 2018-11-15 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
EP3635132A4 (en) * 2017-06-07 2021-05-26 Intrexon Corporation EXPRESSION OF NOVEL CELL MARKERS
AU2018321105B2 (en) 2017-08-21 2025-01-30 European Molecular Biology Laboratory Improved transposase polypeptide and uses thereof
AU2018335274B2 (en) 2017-09-20 2025-02-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HLA class II–restricted T cell receptors against mutated RAS
IL273515B2 (en) 2017-09-29 2026-03-01 Us Health T cell receptors that recognize mutated P53
JP7391015B2 (ja) 2017-09-29 2023-12-04 アメリカ合衆国 P53がん特異的変異に対して抗原特異性を有するt細胞を単離する方法
US12227554B2 (en) 2017-10-05 2025-02-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for selectively expanding cells expressing a TCR with a murine constant region
MX2020005765A (es) 2017-12-04 2020-09-25 Us Health Receptores de celulas t restringidos a antigeno leucocitario humano (hla) clase i contra sarcoma de rata (ras) mutado.
WO2019160956A1 (en) * 2018-02-13 2019-08-22 Novartis Ag Chimeric antigen receptor therapy in combination with il-15r and il15
EP3561053A1 (en) * 2018-04-26 2019-10-30 Baylor College of Medicine Immune effector cells and molecular adaptors with an antigen cytokine complex for effective cancer immunotherapy
AU2019263233B2 (en) 2018-05-01 2024-08-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors which recognize mutated EGFR
US20200129555A1 (en) 2018-10-24 2020-04-30 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Hla-a3-restricted t cell receptors against mutated ras
US20220033848A1 (en) * 2018-11-19 2022-02-03 Board Of Regents, The University Of Texas System A modular, polycistronic vector for car and tcr transduction
WO2020154275A1 (en) 2019-01-22 2020-07-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hla class ii-restricted t cell receptors against ras with g12r mutation
WO2020264269A1 (en) 2019-06-27 2020-12-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors recognizing r175h or y220c mutation in p53
CA3168015A1 (en) 2020-02-12 2021-08-19 Noam LEVIN Hla class i-restricted t cell receptors against ras with g12d mutation
MX2022009825A (es) 2020-02-14 2022-10-13 Us Health Receptores de células t restringidas por hla de la clase i contra ras con mutación g12v.
US20230159614A1 (en) 2020-02-26 2023-05-25 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Hla class ii-restricted t cell receptors against ras with g12v mutation

Similar Documents

Publication Publication Date Title
JP2023106599A5 (cg-RX-API-DMAC10.html)
JP2022512994A5 (cg-RX-API-DMAC10.html)
Baldwin et al. Crystal structure of interleukin 8: symbiosis of NMR and crystallography.
ES2199941T3 (es) Anticuerpos monoclonales contra el receptor de la interferona, con actividad neutralizadora contra el interferon de tipo j.
JP2013505734A5 (cg-RX-API-DMAC10.html)
JP2019150066A5 (cg-RX-API-DMAC10.html)
JP2023504914A5 (cg-RX-API-DMAC10.html)
JP2023505492A5 (cg-RX-API-DMAC10.html)
JP2005514901A5 (cg-RX-API-DMAC10.html)
Sharma et al. A knowledgebase resource for interleukin‐17 family mediated signaling
JP2023525960A5 (cg-RX-API-DMAC10.html)
JP2022522404A5 (cg-RX-API-DMAC10.html)
D'Suze et al. Molecular cloning and nucleotide sequence analysis of genes from a cDNA library of the scorpion Tityus discrepans
JP2024520868A5 (cg-RX-API-DMAC10.html)
CN106117354A (zh) 一种全人源抗CD47的全分子IgG抗体及其应用
JP2021531834A5 (cg-RX-API-DMAC10.html)
JP2018506287A5 (cg-RX-API-DMAC10.html)
JP2023553694A5 (cg-RX-API-DMAC10.html)
JP2023086734A5 (cg-RX-API-DMAC10.html)
JP2025508371A5 (cg-RX-API-DMAC10.html)
CN110582512A (zh) 针对il-17a和il-17f二者的单克隆抗体及其用途
Hoeng et al. Identification of new human cadherin genes using a combination of protein motif search and gene finding methods
Shu-Yuan et al. Nucleotide and deduced amino acid sequences of the M and S genome segments of two Puumala virus isolates from Russia
Pal et al. Molecular characterization and SNP detection of CD14 gene of crossbred cattle
ES2434721T3 (es) Un gen que codifica un homólogo de glicoproteína P humana multifármaco-resistente en el cromosoma 7p15-21 y usos del mismo